{
    "symbol": "MRNS",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-11 14:12:06",
    "content": " And certainly, we feel very good that if we choose to do an interim, we have an 80% power to hit what we think is the key secondary endpoint around date mechanical ventilation, which my view going into the launch Joe, and I haven't talked about this was that this would be -- this study is so incredibly important for the data to drive reimbursement in the hospital and we all know that's a difficult environment. The only way we can do this with a small sales organization successfully is that we've got these great centers of excellence that we have really a meaningful number of refractory epilepsy centers, but I think the way we're thinking about our continued success in '23 is by maximizing the data sets available to us to make sure that we're going to the right physicians."
}